Case study · Pharmaceuticals · Renewal support
This ServiceNow pharma true up defense case study shows how a pharmaceutical firm turned a mid term true up demand priced at undiscounted rates into a settlement at roughly a third of the original figure, using benchmark data from real enterprise renewals.
Reduction in the true up demand
Avoided versus the opening demand
Weeks to settlement
This ServiceNow pharma true up defense case study follows a global pharmaceutical firm that received a true up demand part way through its term, asserting that platform usage in its validated estate had run ahead of entitlements. The demand proposed a substantial mid term charge at undiscounted rates and arrived with a short notice window. The firm brought us in on the buyer side to test the claim before agreeing to anything, rather than treating the demand as a settled invoice.
A pharmaceutical estate carries complexity that a generic usage read tends to miss. The firm ran validated non production instances alongside production, used a large contractor population on fixed assignments, and relied on service and integration accounts to connect ServiceNow to laboratory and quality systems. The vendor's read counted much of this as billable named fulfiller usage. The headline number combined two assertions: that the licensed fulfiller count had been exceeded, and that activity in the validated instances should be counted toward the production entitlement. Procurement faced pressure to settle quickly with the renewal also approaching inside the year.
Our first task was to separate the demand into its component claims and to measure each against the firm's own records and the structure of its estate, because a true up priced at undiscounted rates rewards speed of settlement over accuracy of measurement. We slowed the process and reconciled the estate before any number was accepted.
Reconciliation undercut both claims. A meaningful share of the disputed fulfiller usage came from service and integration accounts that did not map to named individuals and did not require a full fulfiller license under a correct reading of the role definitions. Another slice came from contractors whose assignments had ended but whose accounts had not been deactivated. The activity flagged in the validated non production instances was development and qualification work that the contract did not count toward the production entitlement. Once service accounts, ended contractors and non production activity were isolated, the genuine overage was a fraction of the headline demand.
We built the defense around three moves. First, a corrected usage baseline that applied the contractual role definitions and removed service accounts, integration accounts and ended contractor records from the disputed figure. Second, an estate analysis that separated validated non production instances from production, so qualification work was not charged as production use, drawing on the approach in our ServiceNow renewal negotiation work. Third, a pricing position that any remaining true up be charged at the firm's negotiated rates rather than at list, consistent with the rest of the agreement. Because clause language was at issue, we noted that final contract language should be reviewed by counsel.
The firm's team led the conversation with the account team. We stayed on the buyer side behind it, preparing the reconciliation, drafting the counter position, and briefing the negotiators before each exchange, in the pattern set out in our broader ServiceNow renewal guidance.
The true up settled at roughly a third of the original demand, with the remaining charge priced at the firm's negotiated rates rather than at list. The role definitions were tightened so service and integration accounts were explicitly excluded from the named fulfiller count, and a deactivation practice was written into the firm's process so ended contractors left the billable base on schedule. The validated non production instances were formally separated from production counting in the agreement. The firm avoided an estimated 2.1 million dollars relative to the opening demand. For related work, see our healthcare true up defense and logistics true up defense case studies.
Three lessons carry beyond this engagement. In a regulated estate, service accounts, integration accounts and validated non production instances must be excluded from the named fulfiller count, because counting them inflates a true up by design. A contractor population needs a standing deactivation practice, so ended assignments leave the billable base on schedule rather than at the next measurement. And any genuine true up should be priced at negotiated rates, not at list, consistent with the rest of the agreement. All figures here are typical negotiated ranges based on benchmark observations, used as internal leverage rather than published list prices.
The pharmaceutical firm received a mid term true up demand priced at undiscounted rates after a validated environment expanded. By reconciling contractor and service account usage against the contractual role definitions and separating non production instances from production, the charge settled at roughly a third of the original demand at negotiated rates, avoiding an estimated 2.1 million dollars.
No. The case study is anonymised. It is based on real enterprise renewal engagements, with the industry, estate and figures presented as plausible and internally consistent ranges rather than naming any organisation.
Reconcile the disputed usage against your own records, separate validated non production instances from production, exclude service and integration accounts that do not map to named fulfillers, and insist any genuine true up is priced at your negotiated rates rather than at list.
No. All figures are typical negotiated ranges based on benchmark observations across real enterprise renewals, used as internal leverage rather than published as official list prices.
Your renewal